Now Is the Time to Incorporate Anti-Inflammatory Therapies Into ASCVD Treatment Plans

Now Is the Time to Incorporate Anti-Inflammatory Therapies Into ASCVD Treatment Plans is organized by Pri-Med.

Release Date: 08/06/2025
Expiration Date: 08/06/2026

Description:
This session will explore the evolving landscape of secondary prevention in atherosclerotic cardiovascular disease (ASCVD), emphasizing the need to go beyond statin therapy to further reduce major adverse cardiovascular events (MACE). Participants will examine emerging evidence on nonstatin therapies, including recent data on the use of colchicine for ASCVD event reduction. The program will also guide clinicians in applying current professional guidelines and expert insights to personalize treatment strategies that target inflammatory pathways and improve patient outcomes.

Learning Objectives:

• Explain why treating ASCVD in secondary prevention must go beyond statins with nonstatin therapies to further reduce major adverse cardiovascular events (MACE)
• Discuss recent data of colchicine targeting ASCVD event reduction
• Apply professional guidelines and expert opinion in a personalized approach targeting inflammation pathways to reduce ASCVD events

Topics:

• Cardiology
• Vascular Medicine